Indian drug makers end generic bids

18-04-2016

Indian drug makers end generic bids

pimpic / Shutterstock.com

Indian-based drugs companies BDR Pharmaceutical and Lee Pharmaceutical have reportedly abandoned their attempt to produce generic versions of two drugs developed by AstraZeneca and Bristol-Myers Squibb (BMS).


AstraZeneca, BDR Pharmaceutical, Lee Pharmaceutical, BMS, patent, generics, ETHeathworld.com, Narendra Modi,

LSIPR